{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:36:18Z","timestamp":1772148978578,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1136\/ard-2024-225650","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:25:24Z","timestamp":1711733124000},"page":"961-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-8322","authenticated-orcid":false,"given":"Sharon","family":"Cowley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Harkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colm","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3362","authenticated-orcid":false,"given":"Richard","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-225650_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-225650_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2024-225650_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943574","article-title":"Contribution of pathogenic T helper 1 and 17 cells to bursitis and Tenosynovitis in Polymyalgia Rheumatica","volume":"13","author":"Reitsema","year":"2022","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2024-225650_bib4","first-page":"506","article-title":"The spectrum of giant cell arteritis and Polymyalgia Rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225650_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of Polymyalgia Rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2024-225650_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"Recommendations for the management of Polymyalgia Rheumatica: a European League against rheumatism\/American college of rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/41.1.46","article-title":"Incidence of temporal arteritis in patients with Polymyalgia Rheumatica: a prospective study using colour Doppler Ultrasonography of the temporal arteries","volume":"41","author":"Schmidt","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225650_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2008-1035176","article-title":"Color Doppler ultrasound of the temporal arteries-a new method for diagnosing temporal arteritis","volume":"208","author":"Kraft","year":"1996","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1136\/ard-2024-225650_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset Polymyalgia Rheumatica a systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2024-225650_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221149963","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed Polymyalgia Rheumatica - a prospective cohort study","volume":"15","author":"Burg","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1136\/ard-2024-225650_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in Polymyalgia Rheumatica","volume":"63","author":"De Miguel","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225650_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in Polymyalgia Rheumatica","volume":"83","author":"De Miguel","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib13","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1136\/ard-2024-225650_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216213","article-title":"\u2018Slope sign\u2019: a feature of large vessel vasculitis","volume":"78","author":"Dasgupta","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/annrheumdis-2019-216343","article-title":"Novel ultrasonographic halo score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia","volume":"79","author":"van der Geest","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT Ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kex173","article-title":"The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the Rheumatologist","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225650_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib20","article-title":"Recommendations for early referral of individuals with suspected Polymyalgia Rheumatica: an initiative from the International giant cell arteritis and Polymyalgia Rheumatica study group","author":"Keller","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225650_bib21","first-page":"75","article-title":"Clinical phenotype of patients with Subclinical giant cell arteritis in Polymyalgia Rheumatica [abstract]","author":"Cowley","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2024-225650_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive (18)F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent Polymyalgia Rheumatica","volume":"48","author":"Prieto-Pe\u00f1a","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2024-225650_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255131","article-title":"The added value of 18F-FDG PET\/CT in the assessment of Onset and steroid resistant Polimyalgia Rheumatica","volume":"16","author":"Moya-Alvarado","year":"2021","journal-title":"PLoS One"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-225650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:00:18Z","timestamp":1736056818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0003496724000177"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-225650","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-225650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}